Leslie Leahy

705 total citations
9 papers, 569 citations indexed

About

Leslie Leahy is a scholar working on Molecular Biology, Psychiatry and Mental health and Pathology and Forensic Medicine. According to data from OpenAlex, Leslie Leahy has authored 9 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Psychiatry and Mental health and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Leslie Leahy's work include Cancer therapeutics and mechanisms (2 papers), Electroconvulsive Therapy Studies (2 papers) and Bipolar Disorder and Treatment (2 papers). Leslie Leahy is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Electroconvulsive Therapy Studies (2 papers) and Bipolar Disorder and Treatment (2 papers). Leslie Leahy collaborates with scholars based in United States, Switzerland and Italy. Leslie Leahy's co-authors include Ross J. Baldessarini, Douglas Gause, John Hennen, Stephen Arcona, Jane Pei‐Chen Chang, Henry J. Henk, Donald Goff, Ileana Berman, Andrew C. Leon and Gary Lynch and has published in prestigious journals such as Blood, Neurology and Psychiatric Services.

In The Last Decade

Leslie Leahy

9 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leslie Leahy United States	5	394	112	109	88	59	9	569
Keisuke Motomura Japan	8	230 0.6×	98 0.9×	38 0.3×	69 0.8×	32 0.5×	13	373
A Howard United States	13	563 1.4×	107 1.0×	94 0.9×	79 0.9×	110 1.9×	17	800
Adam L. Meyers United States	13	246 0.6×	30 0.3×	149 1.4×	63 0.7×	64 1.1×	25	552
Johan Szamosi Sweden	13	334 0.8×	48 0.4×	333 3.1×	83 0.9×	36 0.6×	38	684
Raffaella Ardau Italy	16	482 1.2×	47 0.4×	48 0.4×	129 1.5×	61 1.0×	33	696
Andrew Miller United States	12	393 1.0×	221 2.0×	121 1.1×	296 3.4×	24 0.4×	19	747
Joshua Burke United States	11	285 0.7×	79 0.7×	45 0.4×	45 0.5×	27 0.5×	29	712
Boris Finkel Israel	14	342 0.9×	194 1.7×	37 0.3×	129 1.5×	121 2.1×	19	655
Alma Mihaljević Peleš Croatia	15	222 0.6×	91 0.8×	77 0.7×	69 0.8×	72 1.2×	26	575
Hiroshi Mitsuyasu Japan	8	244 0.6×	34 0.3×	39 0.4×	32 0.4×	45 0.8×	9	333

Countries citing papers authored by Leslie Leahy

Since Specialization

Citations

This map shows the geographic impact of Leslie Leahy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Leahy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Leahy more than expected).

Fields of papers citing papers by Leslie Leahy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Leahy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Leahy. The network helps show where Leslie Leahy may publish in the future.

Co-authorship network of co-authors of Leslie Leahy

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Leahy. A scholar is included among the top collaborators of Leslie Leahy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Leahy. Leslie Leahy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Dhakal, Binod, Andrew J. Yee, Paul G. Richardson, et al.. (2024). Initial Results of a Phase 1 First-in-Human Study of Cemsidomide (CFT7455), a Novel MonoDACTM Degrader, with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 144(Supplement 1). 3366–3366. 4 indexed citations

Horwitz, Steven M., Salvia Jain, Jacob D. Soumerai, et al.. (2024). Initial Results of a Phase 1 First-in-Human Study of Cemsidomide (CFT7455), a Novel MonoDACTM Degrader, in Patients with Non-Hodgkin's Lymphoma. Blood. 144(Supplement 1). 467–467. 4 indexed citations

Leahy, Leslie, et al.. (2023). Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is commonly misdiagnosed as Frontotemporal Dementia (FTD), Multiple Sclerosis (MS,) Alzheimer’s disease (AD), or other adult-onset leukodystrophies (P12-4.003). Neurology. 100(17_supplement_2). 1 indexed citations

Papapetropoulos, Spyridon, et al.. (2023). Refining the phenotype of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a commonly misdiagnosed autosomal dominant neurodegenerative disease (S49.010). Neurology. 100(17_supplement_2). 1 indexed citations

Halper, June, Diego Centonze, Scott D. Newsome, et al.. (2015). Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a. International Journal of MS Care. 18(4). 211–218. 20 indexed citations

Baldessarini, Ross J., et al.. (2008). Psychotropic Medications for Patients With Bipolar Disorder in the United States: Polytherapy and Adherence. Psychiatric Services. 59(10). 1175–1183. 141 indexed citations

Baldessarini, Ross J., et al.. (2007). Patterns of Psychotropic Drug Prescription for U.S. Patients With Diagnoses of Bipolar Disorders. Psychiatric Services. 58(1). 85–91. 216 indexed citations

Goff, Donald, Leslie Leahy, Ileana Berman, et al.. (2001). A Placebo-Controlled Pilot Study of the Ampakine CX516 Added to Clozapine in Schizophrenia. Journal of Clinical Psychopharmacology. 21(5). 484–487. 167 indexed citations

Gelenberg, Alan J., et al.. (1990). A crossover study of lecithin treatment of tardive dyskinesia.. PubMed. 51(4). 149–53. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact